Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

L'Oréal (OREP.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-01-24366.35450.00Buy
2022-04-20353.65465.00Buy
2022-08-01369.25483.00Buy
2022-10-14326.35404.00Buy
2023-04-13424.10485.00Buy
2023-04-20429.55495.00Buy
2024-01-15424.20475.00Neutral
2024-02-12428.65465.00Neutral
2024-04-12414.50460.00Neutral
2024-04-18423.60467.00Neutral
2024-07-05410.05459.00Neutral
2024-08-01387.85440.00Neutral
2024-10-15376.40415.00Neutral
2024-10-22367.25409.00Neutral
2025-01-10327.40367.00Neutral
2025-04-14350.80353.00Neutral

Disclosures

  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.